| Revision as of 08:55, 20 February 2012 editBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Saving copy of the {{drugbox}} taken from revid 456517128 of page Pridinol for the Chem/Drugbox validation project (updated: 'DrugBank', 'CAS_number'). |
Latest revision as of 09:13, 31 December 2022 edit Whywhenwhohow (talk | contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers49,178 edits ATC 2023 |
| Line 1: |
Line 1: |
|
|
{{short description|Chemical compound}} |
|
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid of page ] with values updated to verified values.}} |
|
|
{{Drugbox |
|
{{Drugbox |
|
| Verifiedfields = changed |
|
| Verifiedfields = changed |
|
| Watchedfields = changed |
|
| Watchedfields = changed |
|
| verifiedrevid = 424829659 |
|
| verifiedrevid = 477852786 |
|
| IUPAC_name = 1,1-diphenyl-3-(piperidin-1-yl)propan-1-ol |
|
| IUPAC_name = 1,1-Diphenyl-3-(piperidin-1-yl)propan-1-ol |
|
| image = pridinol.png |
|
| image = pridinol.png |
|
|
|
|
|
<!--Clinical data--> |
|
<!--Clinical data--> |
|
| tradename = |
|
| tradename = Myopridin |
|
| Drugs.com = {{drugs.com|international|pridinol}} |
|
| Drugs.com = {{drugs.com|international|pridinol}} |
|
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|
| pregnancy_US = <!-- A / B / C / D / X --> |
|
|
| pregnancy_category = |
|
| pregnancy_category = |
|
⚫ |
| routes_of_administration = ], parenteral |
|
⚫ |
| ATC_prefix = M03 |
|
⚫ |
| ATC_suffix = BX03 |
|
|
| ATC_supplemental = combinations {{ATC|M03|BX53}} |
|
|
|
|
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> |
|
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> |
|
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> |
|
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> |
|
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> |
|
| legal_UK = POM |
|
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
|
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
|
| legal_status = |
|
| legal_status = |
| ⚫ |
| routes_of_administration = |
|
|
|
|
|
|
<!--Pharmacokinetic data--> |
|
<!--Pharmacokinetic data--> |
| Line 25: |
Line 28: |
|
| metabolism = |
|
| metabolism = |
|
| elimination_half-life = |
|
| elimination_half-life = |
|
| excretion = |
|
| excretion = |
|
|
|
|
|
<!--Identifiers--> |
|
<!--Identifiers--> |
|
| CAS_number_Ref = {{cascite|correct|??}} |
|
| CAS_number_Ref = {{cascite|changed|??}} |
|
| CAS_number = <!-- blanked - oldvalue: 511-45-5 --> |
|
| CAS_number = 511-45-5 |
| ⚫ |
| ATC_prefix = M03 |
|
| ⚫ |
| ATC_suffix = BX03 |
|
|
| PubChem = 4904 |
|
| PubChem = 4904 |
|
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|
| DrugBank_Ref = {{drugbankcite|changed|drugbank}} |
|
| DrugBank = <!-- blanked - oldvalue: APRD00264 --> |
|
| DrugBank = DB00945 |
|
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ChemSpiderID = 4735 |
|
| ChemSpiderID = 4735 |
|
| UNII_Ref = {{fdacite|changed|FDA}} |
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
| UNII = 9E75Q6SUUB |
|
| UNII = 9E75Q6SUUB |
|
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
|
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
|
| ChEMBL = 404215 |
|
| ChEMBL = 404215 |
|
|
|
|
|
<!--Chemical data--> |
|
<!--Chemical data--> |
|
| C=20 | H=25 | N=1 | O=1 |
|
| C=20 | H=25 | N=1 | O=1 |
|
| molecular_weight = 295.419 g/mol |
|
|
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChI = 1S/C20H25NO/c22-20(18-10-4-1-5-11-18,19-12-6-2-7-13-19)14-17-21-15-8-3-9-16-21/h1-2,4-7,10-13,22H,3,8-9,14-17H2 |
|
| StdInChI = 1S/C20H25NO/c22-20(18-10-4-1-5-11-18,19-12-6-2-7-13-19)14-17-21-15-8-3-9-16-21/h1-2,4-7,10-13,22H,3,8-9,14-17H2 |
| Line 50: |
Line 50: |
|
| StdInChIKey = RQXCLMGKHJWMOA-UHFFFAOYSA-N |
|
| StdInChIKey = RQXCLMGKHJWMOA-UHFFFAOYSA-N |
|
}} |
|
}} |
|
|
|
|
|
'''Pridinol''', sold under the brand name '''Myopridin''', is a ] that is used as an ]ian and ] drug.<ref>{{cite book| veditors = Budavari S |title=The Merck index an encyclopedia of chemicals, drugs, and biologicals|date=1989|publisher=Merck|location=Rahway, NJ|isbn=091191028X|page=|edition=11th ed., 2nd print.|url-access=registration|url=https://archive.org/details/merckindexency00buda/page/7747}}</ref> |
|
|
|
|
|
It was approved for medical use in the UK in May 2020.<ref>{{cite web | title=Pridinol | website=SPS - Specialist Pharmacy Service | date=10 August 2020 | url=https://www.sps.nhs.uk/medicines/pridinol/ | access-date=21 August 2020}}</ref> |
|
|
|
|
|
==References== |
|
|
{{Reflist}} |
|
|
|
|
|
== External links == |
|
|
* {{cite web | url = https://druginfo.nlm.nih.gov/drugportal/name/pridinol | publisher = U.S. National Library of Medicine | work = Drug Information Portal | title = Pridinol }} |
|
|
|
|
|
{{Muscle relaxants}} |
|
|
{{Muscarinic acetylcholine receptor modulators}} |
|
|
{{Portal bar | Medicine}} |
|
|
|
|
|
] |
|
|
] |
|
|
] |
|
|
] |
|
|
] |
|
|
] |
|
|
|
|
|
|
|
|
{{musculoskeletal-drug-stub}} |